Associated Papers
A structure-based in silico analysis of the Kell blood group system.
Mayr G et al.
Frontiers in Immunology, 2024
Altered cytoplasmic and nuclear ADP-ribosylation levels analyzed with an improved ADP-ribose binder are a prognostic factor in renal cell carcinoma.
Schraml P et al.
The Journal of Pathology. Clinical Research, 2023
36999983 (PubMed )
Supplement: CJP2-9-273-s001.xlsx › Tumor_19
Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
Williams EA et al.
Acta Neuropathologica Communications, 2020
33087175 (PubMed )
Supplement: 40478_2020_1040_MOESM1_ESM.xlsx › Sheet1
Next-Generation Sequencing Technologies in Blood Group Typing.
Fürst D et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie, 2020
Genomic coordinates and continental distribution of 120 blood group variants reported by the 1000 Genomes Project.
Montemayor-Garcia C et al.
Transfusion, 2018
Molecular basis of two novel and related high-prevalence antigens in the Kell blood group system, KUCI and KANT, and their serologic and spatial association with K11 and KETI.
Velliquette RW et al.
Transfusion, 2013
Functional and structural aspects of the Kell blood group system.
Lee S et al.
Transfusion Medicine Reviews, 2000
The KEL24 and KEL14 alleles of the Kell blood group system.
Lee S et al.
Transfusion, 1997
Select a paper to view details